In the BioHarmony Drug Report Database

"Preview" Icon

Atazanavir

Reyataz (atazanavir) is a small molecule pharmaceutical. Atazanavir was first approved as Reyataz on 2003-06-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.

 

Trade Name

 

Reyataz
 

Common Name

 

atazanavir
 

ChEMBL ID

 

CHEMBL1163
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Antivirals: HIV protease inhibitors (saquinavir type)

Image (chem structure or protein)

Atazanavir structure rendering